Diclofenac Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 46 pharmaceutical companies such as UNIQUE, ACTAVIS LABS FL INC, SANDOZ and others. It is marketed under 8 brand names, including DICLOFENAC SODIUM, DICLOFENAC SODIUM AND MISOPROSTOL, ZORVOLEX and others. Available in 15 different strengths, such as 25MG, 50MG, 75MG;0.2MG and others, and administered through 10 routes including TABLET, DELAYED RELEASE;ORAL, CAPSULE;ORAL, GEL;TOPICAL and others. The latest reported annual revenue is $336,724,831 in 2024.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 46 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

Comprehensive global patent expiry timelines
Full patent family details and status updates

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

Comprehensive global patent expiry timelines
Full patent family details and status updates
Latest exclusivity data and extensions

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

Comprehensive global patent expiry timelines
Full patent family details and status updates

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"56920","ingredient":"DICLOFENAC POTASSIUM","trade_name":"CAMBIA","family_id":"2ce676bd32fe4fa3b348","publication_number":"US8097651B2","cleaned_patent_number":"8097651","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-06-16","publication_date":"2012-01-17","legal_status":"Granted"} US8097651B2 Molecular Formulation 17 Jan, 2012 Granted 16 Jun, 2026
{"application_id":"56952","ingredient":"DICLOFENAC POTASSIUM","trade_name":"CAMBIA","family_id":"2ce676bd32fe4fa3b348","publication_number":"US9827197B2","cleaned_patent_number":"9827197","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-06-16","publication_date":"2017-11-28","legal_status":"Granted"} US9827197B2 Formulation 28 Nov, 2017 Granted 16 Jun, 2026
{"application_id":"56951","ingredient":"DICLOFENAC POTASSIUM","trade_name":"CAMBIA","family_id":"2ce676bd32fe4fa3b348","publication_number":"US8927604B2","cleaned_patent_number":"8927604","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-06-16","publication_date":"2015-01-06","legal_status":"Granted"} US8927604B2 06 Jan, 2015 Granted 16 Jun, 2026
{"application_id":"56950","ingredient":"DICLOFENAC POTASSIUM","trade_name":"CAMBIA","family_id":"2ce676bd32fe4fa3b348","publication_number":"US7759394B2","cleaned_patent_number":"7759394","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-06-16","publication_date":"2010-07-20","legal_status":"Granted"} US7759394B2 Molecular Formulation 20 Jul, 2010 Granted 16 Jun, 2026
{"application_id":"73508","ingredient":"DICLOFENAC SODIUM","trade_name":"DYLOJECT","family_id":"7d1b12cad9db45ecb7eb","publication_number":"US8946292B2","cleaned_patent_number":"8946292","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-03-22","publication_date":"2015-02-03","legal_status":"Patented case"} US8946292B2 03 Feb, 2015 Patented case 22 Mar, 2027
{"application_id":"80622","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"866b3cb486d249fabf9e","publication_number":"US9339552B2","cleaned_patent_number":"9339552","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-10-17","publication_date":"2016-05-17","legal_status":"Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362"} US9339552B2 Formulation 17 May, 2016 Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362 17 Oct, 2027
{"application_id":"80615","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"866b3cb486d249fabf9e","publication_number":"US8563613B2","cleaned_patent_number":"8563613","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-10-17","publication_date":"2013-10-22","legal_status":"Patented case"} US8563613B2 Formulation 22 Oct, 2013 Patented case 17 Oct, 2027
{"application_id":"80616","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"866b3cb486d249fabf9e","publication_number":"US8871809B2","cleaned_patent_number":"8871809","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-10-17","publication_date":"2014-10-28","legal_status":"Patented case"} US8871809B2 28 Oct, 2014 Patented case 17 Oct, 2027
{"application_id":"80623","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"866b3cb486d249fabf9e","publication_number":"US9539335B2","cleaned_patent_number":"9539335","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-10-17","publication_date":"2017-01-10","legal_status":"Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362"} US9539335B2 10 Jan, 2017 Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362 17 Oct, 2027
{"application_id":"80617","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"866b3cb486d249fabf9e","publication_number":"US9066913B2","cleaned_patent_number":"9066913","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-10-17","publication_date":"2015-06-30","legal_status":"Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362"} US9066913B2 Formulation 30 Jun, 2015 Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362 17 Oct, 2027
{"application_id":"80618","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"866b3cb486d249fabf9e","publication_number":"US9101591B2","cleaned_patent_number":"9101591","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-10-17","publication_date":"2015-08-11","legal_status":"Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362"} US9101591B2 Formulation 11 Aug, 2015 Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362 17 Oct, 2027
{"application_id":"80588","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"f746902db5954ef7bb2e","publication_number":"US9132110B2","cleaned_patent_number":"9132110","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-10-17","publication_date":"2015-09-15","legal_status":"Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362"} US9132110B2 15 Sep, 2015 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 17 Oct, 2027
{"application_id":"80619","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"866b3cb486d249fabf9e","publication_number":"US9168304B2","cleaned_patent_number":"9168304","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-10-17","publication_date":"2015-10-27","legal_status":"Granted"} US9168304B2 Formulation 27 Oct, 2015 Granted 17 Oct, 2027
{"application_id":"80599","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"866b3cb486d249fabf9e","publication_number":"US9168305B2","cleaned_patent_number":"9168305","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-10-17","publication_date":"2015-10-27","legal_status":"Patented case"} US9168305B2 27 Oct, 2015 Patented case 17 Oct, 2027
{"application_id":"80620","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"866b3cb486d249fabf9e","publication_number":"US9220784B2","cleaned_patent_number":"9220784","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-10-17","publication_date":"2015-12-29","legal_status":"Patented case"} US9220784B2 29 Dec, 2015 Patented case 17 Oct, 2027
{"application_id":"80621","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"866b3cb486d249fabf9e","publication_number":"US9339551B2","cleaned_patent_number":"9339551","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-10-17","publication_date":"2016-05-17","legal_status":"Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362"} US9339551B2 17 May, 2016 Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362 17 Oct, 2027
{"application_id":"80614","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"866b3cb486d249fabf9e","publication_number":"US8252838B2","cleaned_patent_number":"8252838","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-04-21","publication_date":"2012-08-28","legal_status":"Expired"} US8252838B2 Formulation 28 Aug, 2012 Expired 21 Apr, 2028
{"application_id":"53896","ingredient":"DICLOFENAC POTASSIUM","trade_name":"ZIPSOR","family_id":"6f53e1029da84f8985db","publication_number":"US7884095B2","cleaned_patent_number":"7884095","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-02-24","publication_date":"2011-02-08","legal_status":"Patented case"} US7884095B2 08 Feb, 2011 Patented case 24 Feb, 2029
{"application_id":"53897","ingredient":"DICLOFENAC POTASSIUM","trade_name":"ZIPSOR","family_id":"6f53e1029da84f8985db","publication_number":"US7662858B2","cleaned_patent_number":"7662858","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-02-24","publication_date":"2010-02-16","legal_status":"Patented case"} US7662858B2 16 Feb, 2010 Patented case 24 Feb, 2029
{"application_id":"53899","ingredient":"DICLOFENAC POTASSIUM","trade_name":"ZIPSOR","family_id":"6f53e1029da84f8985db","publication_number":"US8110606B2","cleaned_patent_number":"8110606","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-02-24","publication_date":"2012-02-07","legal_status":"Patented case"} US8110606B2 07 Feb, 2012 Patented case 24 Feb, 2029
{"application_id":"53901","ingredient":"DICLOFENAC POTASSIUM","trade_name":"ZIPSOR","family_id":"6f53e1029da84f8985db","publication_number":"US9561200B2","cleaned_patent_number":"9561200","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-02-24","publication_date":"2017-02-07","legal_status":"Patented case"} US9561200B2 07 Feb, 2017 Patented case 24 Feb, 2029
{"application_id":"53900","ingredient":"DICLOFENAC POTASSIUM","trade_name":"ZIPSOR","family_id":"6f53e1029da84f8985db","publication_number":"US8623920B2","cleaned_patent_number":"8623920","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-02-24","publication_date":"2014-01-07","legal_status":"Patented case"} US8623920B2 07 Jan, 2014 Patented case 24 Feb, 2029
{"application_id":"53898","ingredient":"DICLOFENAC POTASSIUM","trade_name":"ZIPSOR","family_id":"6f53e1029da84f8985db","publication_number":"US7939518B2","cleaned_patent_number":"7939518","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-02-24","publication_date":"2011-05-10","legal_status":"Patented case"} US7939518B2 10 May, 2011 Patented case 24 Feb, 2029
{"application_id":"80584","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"f746902db5954ef7bb2e","publication_number":"US8741956B2","cleaned_patent_number":"8741956","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-07-10","publication_date":"2014-06-03","legal_status":"Granted"} US8741956B2 03 Jun, 2014 Granted 10 Jul, 2029
{"application_id":"80589","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"f746902db5954ef7bb2e","publication_number":"US9370501B2","cleaned_patent_number":"9370501","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-07-10","publication_date":"2016-06-21","legal_status":"Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362"} US9370501B2 21 Jun, 2016 Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362 10 Jul, 2029
{"application_id":"80591","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"f746902db5954ef7bb2e","publication_number":"US9415029B2","cleaned_patent_number":"9415029","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-07-10","publication_date":"2016-08-16","legal_status":"Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362"} US9415029B2 16 Aug, 2016 Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362 10 Jul, 2029
{"application_id":"80587","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"f746902db5954ef7bb2e","publication_number":"US8618164B2","cleaned_patent_number":"8618164","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-07-10","publication_date":"2013-12-31","legal_status":"Granted"} US8618164B2 31 Dec, 2013 Granted 10 Jul, 2029
{"application_id":"80585","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"f746902db5954ef7bb2e","publication_number":"US8217078B1","cleaned_patent_number":"8217078","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-07-10","publication_date":"2012-07-10","legal_status":"Granted"} US8217078B2 10 Jul, 2012 Granted 10 Jul, 2029
{"application_id":"80590","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"f746902db5954ef7bb2e","publication_number":"US9375412B2","cleaned_patent_number":"9375412","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-07-10","publication_date":"2016-06-28","legal_status":"Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362"} US9375412B2 28 Jun, 2016 Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362 10 Jul, 2029
{"application_id":"54107","ingredient":"DICLOFENAC","trade_name":"ZORVOLEX","family_id":"5c442a5ecf5449689acb","publication_number":"US8999387B2","cleaned_patent_number":"8999387","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-04-23","publication_date":"2015-04-07","legal_status":"Patented case"} US8999387B2 07 Apr, 2015 Patented case 23 Apr, 2030
{"application_id":"54105","ingredient":"DICLOFENAC","trade_name":"ZORVOLEX","family_id":"5c442a5ecf5449689acb","publication_number":"US8679544B2","cleaned_patent_number":"8679544","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-04-23","publication_date":"2014-03-25","legal_status":"Granted"} US8679544B2 Formulation 25 Mar, 2014 Granted 23 Apr, 2030
{"application_id":"54108","ingredient":"DICLOFENAC","trade_name":"ZORVOLEX","family_id":"5c442a5ecf5449689acb","publication_number":"US9017721B2","cleaned_patent_number":"9017721","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-04-23","publication_date":"2015-04-28","legal_status":"Granted"} US9017721B2 Formulation 28 Apr, 2015 Granted 23 Apr, 2030
{"application_id":"54109","ingredient":"DICLOFENAC","trade_name":"ZORVOLEX","family_id":"5c442a5ecf5449689acb","publication_number":"US9173854B2","cleaned_patent_number":"9173854","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-04-23","publication_date":"2015-11-03","legal_status":"Granted"} US9173854B2 Formulation 03 Nov, 2015 Granted 23 Apr, 2030
{"application_id":"54110","ingredient":"DICLOFENAC","trade_name":"ZORVOLEX","family_id":"5c442a5ecf5449689acb","publication_number":"US9180095B2","cleaned_patent_number":"9180095","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-04-23","publication_date":"2015-11-10","legal_status":"Granted"} US9180095B2 10 Nov, 2015 Granted 23 Apr, 2030
{"application_id":"54111","ingredient":"DICLOFENAC","trade_name":"ZORVOLEX","family_id":"5c442a5ecf5449689acb","publication_number":"US9180096B2","cleaned_patent_number":"9180096","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-04-23","publication_date":"2015-11-10","legal_status":"Granted"} US9180096B2 Formulation 10 Nov, 2015 Granted 23 Apr, 2030
{"application_id":"54066","ingredient":"DICLOFENAC","trade_name":"ZORVOLEX","family_id":"5c442a5ecf5449689acb","publication_number":"US9186328B2","cleaned_patent_number":"9186328","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-04-23","publication_date":"2015-11-17","legal_status":"Granted"} US9186328B2 17 Nov, 2015 Granted 23 Apr, 2030
{"application_id":"80586","ingredient":"DICLOFENAC SODIUM","trade_name":"PENNSAID","family_id":"f746902db5954ef7bb2e","publication_number":"US8546450B1","cleaned_patent_number":"8546450","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-08-09","publication_date":"2013-10-01","legal_status":"Granted"} US8546450B2 01 Oct, 2013 Granted 09 Aug, 2030
{"application_id":"83613","ingredient":"DICLOFENAC EPOLAMINE","trade_name":"LICART","family_id":"0db459f0c07a409ca107","publication_number":"US11344520B2","cleaned_patent_number":"11344520","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-02-20","publication_date":"2022-05-31","legal_status":"Granted"} US11344520B2 31 May, 2022 Granted 20 Feb, 2035
{"application_id":"83610","ingredient":"DICLOFENAC EPOLAMINE","trade_name":"LICART","family_id":"0db459f0c07a409ca107","publication_number":"US11351133B2","cleaned_patent_number":"11351133","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-02-20","publication_date":"2022-06-07","legal_status":"Granted"} US11351133B2 07 Jun, 2022 Granted 20 Feb, 2035

Drug Prices

Country wise drug prices over the years

Drug Revenues

Country wise drug revenue over the years

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Diclofenac

Access a comprehensive list of global suppliers
Get information on each supplier

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.